Sunniva Estimates Over USD $55 Million Revenue in 2019 From Sunniva Branded Cannabis Products in California and Secures Additional USD $4.0 Million in Purchase Orders
Ionic Brands (CSE: IONC) is creating a multi-state, consumer focused, premium cannabis porfolio consisting of iconic national brands.
They have:
- Stylish products
- World Class Management Team
- A proven and repeatable strategy for success
Experienced and proven luxury cannabis concentrates brand
One of the tops selling vape brands in WA State with a loyal customer base
Largest standalone oil manufacturer in the state of WA
Consistent sales growth over 3 years with a verified marketing blueprint
Offers investors exposure to a premium luxury cannabis brand
Demonstrated to have a winning formula to become the top vape company in WA
Massive growth opportunity available with expansion into OR, NV and CA
Sunniva Estimates Over USD $55 Million Revenue in 2019 From Sunniva Branded Cannabis Products in California and Secures Additional USD $4.0 Million in Purchase Orders
MPX International Corporation (CSE:MPXI) intends to raise up to C$20 million (approximately US$15 million) in a non-brokered private placement offering of up to 41,666,666 units (the “Units”) of the Company at a price of C$0.48 per Unit.
Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) expands its cannabis retail dispensary footprint by announcing a new dispensary in Broward Country Florida.
The Seed Investor's top pick in the Canadian Cannabis Retail space announced some big news, as they entered into an LOI with one of the 25 Ontario Cannabis Retail Lottery Winners.
It’s earnings season for marijuana stocks and, as usual, the financial media are going to drag investors into the insignificant details of quarterly earnings reports. Here’s a chart which will make sure you avoid all this noise and stay focused on the big opportunities still being created in the legal marijuana industry.
InMed Pharmaceuticals released their Q2 financials and provided an update on the advancements of their two scientific priorities, INM-750 and their biosynthesis platform technology.